Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Wang, Xinhua; Zhang, Lei; Liu, Xiangli; Li, Xin; Li, Ling; Fu, Xiaorui; Sun, Zhenchang; Wu, Jingjing; Zhang, Xudong; Yan, Jiaqin; Chang, Yu; Nan, Feifei; Zhou, Zhiyuan; Wu, Xiaolong; Tian, Li; Ma, Minrui; Li, Zhaoming; Yu, Hui; Zhu, Linan; Wang, Yingjun; Shi, Cunzhen; Feng, Xiaoyan; Li, Jiwei; Ding, Mengjie; Zhang, Jieming; Dong, Meng; Xue, Hongwei; Wang, Jinghua; Zou, Liqun; Su, Liping; Wu, Jianqiu; Liu, Lihong; Bao, Huizheng; Zhang, Liling; Guo, Yanzhen; Guo, Shuxia; Lu, Yi; Young, Ken H.; Li, Wencai; Zhang, Mingzhi

Published in

American Medical Association, JAMA Oncology, 7(8), p. 1035, 2022

DOI: 10.1001/jamaoncol.2022.1968

Tools

Export citation

Search in Google Scholar

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Journal article published in 2022 by Xinhua Wang, Lei Zhang, Xiangli Liu, Xin Li, Ling Li, Xiaorui Fu, Zhenchang Sun, Jingjing Wu, Xudong Zhang, Jiaqin Yan, Yu Chang, Feifei Nan, Zhiyuan Zhou, Xiaolong Wu, Li Tian and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma